Tag Archive for: Omnicron

“With some uncertainty on the revenue line, we are also carefully watching our spending by revisiting our cost base,” said finance chief Jens Holstein, adding that BioNTech’s ambition to become a multi-product oncology and infectious disease company was unchanged.

An experimental COVID-19 vaccine in the form of an oral tablet has shown promising immune responses in a small preliminary trial designed mainly to evaluate its safety; High blood pressure more than doubles the risk of hospitalization during COVID-19 infections with the coronavirus Omicron variant, even in people who are fully vaccinated and boosted, a U.S. study showed.